Cellular FLICE-inhibitory protein is required for T cell survival and cycling by Chau, Hien et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
JEM © The Rockefeller University Press $8.00
Vol. 202, No. 3, August 1, 2005 405–413 www.jem.org/cgi/doi/10.1084/jem.20050118
 
ARTICLE
 
405
 
Cellular FLICE-inhibitory protein is required 
for T cell survival and cycling
 
Hien Chau,
 
1,2
 
 Veronica  Wong,
 
1,2
 
 Nien-Jung Chen,
 
1,2
 
 Huey-Lan Huang,
 
1,2
 
 
Wen-Jye Lin,
 
1,2
 
 Christine Mirtsos,
 
1,2
 
 Alisha R. Elford,
 
1,2
 
 
Madeleine Bonnard,
 
3
 
 Andrew Wakeham,
 
1,2
 
 Annick Itie  You-Ten,
 
1,2
 
 
Bénédicte Lemmers,
 
3
 
 Leonardo Salmena,
 
3
 
 Marc Pellegrini,
 
1,2
 
 
 
Razq Hakem,
 
3
 
 Tak  W. Mak,
 
1,2
 
 Pamela Ohashi,
 
1,2
 
 and Wen-Chen Yeh
 
1,2
 
1
 
Campbell Family Institute for Breast Cancer Research, University Health Network and 
 
2
 
Department of Medical Biophysics, 
University of Toronto, Toronto, Ontario, M5G 2C1, Canada
 
3
 
Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9, Canada
 
Fas-associated death domain (FADD) and caspase-8 are key signal transducers for death 
receptor–induced apoptosis, whereas cellular FLICE-inhibitory protein (cFLIP) antagonizes 
this process. Interestingly, FADD and caspase-8 also play a role in T cell development and 
T cell receptor (TCR)–mediated proliferative responses. To investigate the underlying 
mechanism, we generated cFLIP-deficient T cells by reconstituting 
 
Rag
 
 
 
/
 
 
 
 blastocysts with 
cFLIP-deficient embryonic stem cells. These Rag chimeric mutant mice (
 
rcFLIP
 
 
 
/
 
 
 
) had 
severely reduced numbers of T cells in the thymus, lymph nodes, and spleen, although 
mature T lymphocytes did develop. Similar to FADD- or caspase-8–deficient cells, 
 
rcFLIP
 
 
 
/
 
 
 
 
T cells were impaired in proliferation in response to TCR stimulation. Further investigation 
revealed that cFLIP is required for T cell survival, as well as T cell cycling in response to TCR 
stimulation. Interestingly, some signaling pathways from the TCR complex appeared 
competent, as CD3 plus CD28 cross-linking was capable of activating the ERK pathway in 
 
rcFLIP
 
 
 
/
 
 
 
 T cells. We demonstrate an essential role for cFLIP in T cell function.
 
Studies of apoptosis regulation and cell prolifera-
tion are critical to our understanding of various
biological responses, including immune regula-
tion. Proteins containing specialized domains,
such as the death domain (DD) and the death
effector domain (DED), have been found to play
essential roles in regulating apoptotic signals, in-
cluding signals mediated by death receptors
such as the Fas antigen and TNFR1 (1–3).
Death receptor–induced apoptosis requires two
common signal transducers, Fas-associated DD
(FADD) and caspase-8 (4). FADD is a bimodular
adaptor (DED–DD) that interacts with death
receptors or other adaptors through its DD
while recruiting caspase-8 through its DED.
Caspase-8 contains two DEDs that interact
with FADD and a COOH-terminal caspase
domain that can be activated to trigger down-
stream apoptotic cascades (5).
Cellular FLICE-inhibitory protein (cFLIP),
on the other hand, contains two DEDs and a
caspase-like domain similar to that in caspase-8,
but it lacks the signature feature of proteolytic
enzymes (6). Full-length cFLIP (cFLIP
 
L
 
) and
several splice variants of cFLIP (including
cFLIP
 
S
 
) containing truncated caspase-like do-
mains have been described. All cFLIP variants
are capable of binding to the DEDs of FADD
and caspase-8, theoretically allowing them to
physically interfere with caspase-8 recruitment
to FADD (6). Consistent with this hypothesis,
 
cFLIP
 
 
 
/
 
 
 
 mouse embryonic fibroblasts are highly
sensitive to apoptosis induced by TNF or FasL,
indicating that cFLIP is an essential cell survival
factor that counteracts FADD and caspase-8–
mediated apoptosis (7). Interestingly, 
 
cFLIP
 
 
 
/
 
 
 
mice die during embryogenesis with a cardiac
defect similar to that observed in 
 
FADD
 
 
 
/
 
 
 
and 
 
caspase-8
 
 
 
/
 
 
 
 mice (7–9). Thus, this trio of
DED-containing proteins may cooperate in
certain signaling pathways such as that involved
in heart development.
One outstanding question regarding the
physiological functions of FADD and caspase-8
concerns their involvement in T cell develop-
ment, survival, and proliferation. Although both
molecules are required for the Fas-dependent
arm of activation-induced cell death of T cells,
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these proteins also promote proliferation induced by TCR
engagement (10–12). Specifically, in FADD-deficient T
cells, activation in response to TCR stimulation is impaired
and cells do not proliferate (10). Further study of T cell–spe-
cific FADD-deficient mice revealed a role of FADD in early
T cell development (13). Consistent with certain knockout
phenotypes, mutant T cells from transgenic mice overex-
pressing a dominant negative mutant of FADD (FADD-DN)
also show impaired development in the thymus and fail to
proliferate in response to TCR stimulation (14–19).
Recently, an essential role of caspase-8 in T cell prolifer-
ation was demonstrated in both human patients and mouse
models (11, 12). Patients harboring homozygous caspase-8
mutations exhibited defective lymphocyte apoptosis and im-
munodeficiency, primarily caused by abnormal activation of
T, B, and NK cells (12). Mouse peripheral T cells lacking
caspase-8 showed impaired Fas-mediated apoptosis and acti-
vation-induced T cell expansion in vitro (11). More dramati-
cally, deletion of caspase-8 in early hematopoietic precursors
completely abolished T cell development (20). Collectively,
both FADD and caspase-8 may play a role in TCR signals
that affect T cell development and proliferation.
cFLIP is abundantly expressed in T cells (6). Recently,
two laboratory groups have investigated the role of cFLIP in
T lymphocytes using transgenic mice overexpressing cFLIP.
One study demonstrated that cFLIP is important for pro-
moting T cell proliferation. Mutant T cells derived from
these transgenic mice stimulated with suboptimal doses of
anti-CD3 antibody showed enhanced proliferation and IL-2
production (21). In contrast, another group reported that in
response to TCR cross-linking, cFLIP-overexpressing T
cells were impaired in proliferation, as well as in activation of
ERK, p38 mitogen-activated protein kinase, and NF-
 
 
 
B
(22). A third group overexpressed the viral homologue of
cFLIP (vFLIP) in T cells and showed that T cell survival is
perturbed (23). Collectively, it appears that cFLIP is in-
volved in T cell activation, but the exact function of cFLIP
in this process remains very much in debate.
We examined cFLIP-deficient T cells in 
 
Rag
 
 
 
/
 
 
 
 chimerae
(
 
rcFLIP
 
 
 
/
 
 
 
). 
 
rcFLIP
 
 
 
/
 
 
 
 mice had greatly reduced T cell counts
in the thymus and periphery, and TCR-mediated prolifera-
tion was severely impeded in the mutant cells. The resem-
blance of 
 
rcFLIP
 
 
 
/
 
 
 
, 
 
FADD
 
 
 
/
 
 
 
, and 
 
caspase-8
 
 
 
/
 
 
 
 phenotypes
to each other suggests that cFLIP may be a critical molecular
link, at least for FADD and caspase-8, during the process of
TCR signaling that affects T cell survival and proliferation.
 
RESULTS
cFLIP expression is constitutive in T cells and mildly induced 
after TCR stimulation
 
As we were interested in investigating the function of cFLIP
in T cells and, potentially, the connection between cFLIP,
FADD, and/or caspase-8 on TCR stimulation, we first ex-
amined the expression patterns of these proteins in T cells.
Constitutive expression of cFLIP
 
L
 
 in naive T lymphocytes
was readily detectable, and the protein level was mildly en-
hanced on TCR activation. Interestingly cFLIP
 
S
 
 was unde-
tectable in resting lymphocytes but was highly induced 6 h
after CD3 and CD28 cross-linking (Fig. 1). Expression of
FADD and caspase-8, on the other hand, was more or less
constant before and throughout TCR stimulation (Fig. 1).
We further examined the protein expression in a situa-
tion where proliferation was reduced because of the expres-
sion of FADD-DN (14). As shown in Fig. 1, the suboptimal
proliferation of FADD-DN T cells after TCR stimulation
appeared to correlate with the reduced level of c-Myc. In-
terestingly, expression levels of FADD, caspase-8, and cFLIP
in FADD-DN T cells were comparable with those in wild-
type littermate T cells, except that the levels of cFLIP after
TCR stimulation appeared to be slightly accentuated in the
mutant cells (Fig. 1). These data suggested that FADD-DN
could antagonize TCR-mediated proliferative signals through
an alternative mechanism instead of down-regulating any of
the three DED proteins.
 
Generation of 
 
cFLIP
 
 
 
/
 
 
 
/
 
Rag
 
 
 
/
 
 
 
 chimeric mice
 
To evaluate the impact on T cells when cFLIP is absent, we
generated cFLIP-deficient T cells by reconstituting 
 
Rag
 
 
 
/
 
 
 
mice with 
 
cFLIP
 
 
 
/
 
 
 
 embryonic stem (ES) cells. To generate
cFLIP-deficient ES cells, exon 1 of one 
 
cflip
 
 allele was re-
placed with a neomycin cassette, while exon 1 of the other
allele was substituted by a hygromycin resistance gene (Fig. 2
A). Proper genomic recombination with the presence of
both neomycin and hygromycin resistance alleles was con-
firmed using Southern blot analyses (not depicted), and the
absence of cFLIP expression in a homozygous mutant cell
line was demonstrated by Northern blotting (Fig. 2 B). Two
independent 
 
cFLIP
 
 
 
/
 
 
 
 ES cell lines, along with one 
 
cFLIP
 
 
 
/
 
 
 
control line, were used for injections into 
 
Rag
 
 
 
/
 
 
 
 blasto-
cysts to generate the chimeric mice (
 
rcFLIP
 
 
 
/
 
 
 
 and 
 
rcFLIP
 
 
 
/
 
 
 
,
Figure 1. Expression of DED proteins in wild-type and FADD-DN T 
cells. Purified T cells isolated from FADD-DN transgenic mice and wild-type 
littermates were left untreated (0 h) or stimulated with 1  g/ml anti-CD3 
plus 5  g/ml anti-CD28 antibodies for the time points indicated. Protein 
levels of cFLIP (long and short forms), FADD (full length and FADD-DN 
transgene), caspase-8, c-Myc, and actin were determined as described in 
Materials and methods. Arrows indicate the bands corresponding to the 
proteins of interest. 
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respectively). 4 wk after chimeric mice were born, the pres-
ence of reconstituted T lymphocytes in these mice was as-
sessed by tail-blood staining for the presence of CD4 or
CD8 (unpublished data). Because the 
 
caspase-8
 
 and 
 
cflip
 
 gene
loci are close to one another, we examined and confirmed
that caspase-8 expression is equal in 
 
rcFLIP
 
 
 
/
 
 
 
 and control T
cells (unpublished data).
Although peripheral mature T lymphocytes were present
in 
 
rcFLIP
 
 
 
/
 
 
 
 mice, the numbers of total splenocytes and
lymph node cells in these mutant mice were both severely
reduced compared with 
 
rcFLIP
 
 
 
/
 
 
 
 mice. For example,
 
rcFLIP
 
 
 
/
 
 
 
 mice (9.20 
 
 
 
 3.85 
 
 
 
 10
 
6
 
; 
 
n
 
 
 
 
 
 9) had approxi-
mately three- to fourfold fewer total splenocytes than
 
rcFLIP
 
 
 
/
 
 
 
 mice (41.8 
 
 
 
 29.6 
 
 
 
 10
 
6
 
; 
 
n
 
 
 
 
 
 7). In lymph nodes,
the cell numbers of 
 
rcFLIP
 
 
 
/
 
 
 
 mice were reduced by approx-
imately ninefold. Reduction of lymphocyte numbers in
 
rcFLIP
 
 
 
/
 
 
 
 mice was partly caused by a deficiency of B cells,
as B cell development was also impaired in these mutant mice
(unpublished data). Flow cytometric analysis of the lymph
node cells revealed that the ratio of CD4
 
 
 
/CD8
 
 
 
 cells was
comparable between mutant and control T cells (Fig. 2 C).
To further characterize T cells in 
 
rcFLIP /  and rcFLIP / 
mice, thymus cellular profiles were analyzed. Wild-type
129J mouse thymocytes were included in the analysis as a
reference control. Again, the total number of rcFLIP /  thy-
mocytes (2.53   1.40   106; n   7) showed  10-fold re-
duction compared with rcFLIP /  thymocytes (36.7   0.09  
106; n   4). As shown in Fig. 2 D, rcFLIP /  thymi had
a markedly reduced population of double-positive (DP)
CD4 CD8  cells when compared with rcFLIP /  thymi.
Nevertheless, rcFLIP /  thymocytes were capable of reach-
ing the stage of single positive cell development, albeit at re-
duced numbers. Analysis of Ly9.1  (a marker for the recon-
stituted ES cells) double-negative CD4 CD8  thymocytes
by CD25/CD44 staining also revealed a reduction of early
rcFLIP /  thymocytes and some accumulations of CD25 
CD44  and CD25 CD44  cells when compared with the
rcFLIP /  counterparts (Fig. 2 E). Interestingly, we found
that the earlier we analyzed the chimerae, the more thy-
mocytes and DP cells were present in rcFLIP /  mice (un-
published data), suggesting that thymocytes lacking cFLIP
may have an intrinsic survival defect. Similar defects of
thymocyte development and survival were reported in
rFADD /  mice (10).
rcFLIP /  T cells are defective in TCR-stimulated 
proliferation and cell survival
One question of interest was whether cFLIP plays a role in T
cell proliferation in response to TCR stimulation, as this
process is defective in both FADD-deficient and caspase-8–
deficient T cells (10, 11). Purified T cells from rcFLIP /  or
rcFLIP /  mice were stimulated with a low (0.1  g/ml) or
high (1  g/ml) concentration of anti-CD3 antibody, in
the presence or absence of anti-CD28 antibody (1  g/ml),
for 48 h. As measured by [3H]thymidine incorporation,
Figure 2. Generation of cFLIP-deficient T cells. (A) The targeting 
construct. Homologous recombination replaced a part of cFLIP exon 1, 
including the ATG start codon, with the neomycin resistance cassette on 
one of the wild-type alleles, resulting in a heterozygous ES cell line. A 
second targeting construct containing a hygromycin resistance cassette 
replaced the other allele, resulting in a cFLIP-null ES cell line. Primers 
used for PCR screening are indicated by arrows. (B) Absence of cFLIP 
expression confirmed by Northern blot analysis. 20  g of total RNA 
was isolated from homozygous wild-type ( / ), homozygous mutant 
( / ), and heterozygous ( / ) ES cell clones and resolved on a form-
aldehyde-denaturing agarose gel. RNA from a wild-type embryonic 
fibroblast cell line (EF) was also used as a control. The RNA was trans-
ferred to nitrocellulose membrane and probed with a full-length cFLIP 
cDNA probe (top) and a GADPH probe (bottom). (C) Expression of CD4 
and CD8 in rcFLIP /  peripheral T cells. Pooled lymph node cells from 
wild-type and rcFLIP /  mice were stained for the expression of T cell–
specific surface markers, CD4 and CD8, and analyzed by flow cytometry. 
The percentage of gated viable cells in each quadrant of the dot plots is 
shown. (D) Abnormal T cell development in rcFLIP /  chimera. Represen-
tative flow cytometric analyses of thymi from rcFLIP / , rcFLIP / , wild-
type 129J, and Rag /  mice are shown; the latter two were used as 
positive and negative controls, respectively. Thymocytes were stained 
using antibodies against CD4 and CD8 and analyzed by flow cytometry. 
The percentages of gated viable cells for each quadrant of the dot plots 
are shown. (E) Abnormal early thymocyte development in rcFLIP /  
chimera. Lineage-negative (CD4 CD8 ) and Ly9.1-positive thymocytes 
from rcFLIP /  and control mice ( / ) were gated and analyzed for the 
expression of CD25 and CD44. The percentage of gated cells in each 
quadrant is shown.THE ROLE OF CFLIP IN T CELLS | Chau et al. 408
rcFLIP /  T cells failed to proliferate under all stimulatory
conditions when compared with the rcFLIP /  counterparts
(Fig. 3 A). In addition, cFLIP-deficient T cells produced a
reduced amount of IL-2 in response to TCR stimulation
(not depicted), and a supplement of exogenous IL-2 failed to
rescue the defect of proliferation (Fig. 3 A).
To further analyze the impact of cFLIP deficiency on
T cells throughout TCR activation and cell division, the
fluorescent dye carboxyfluorescein diacetate succinimidyl
ester (CFSE) was used to label T cells (24). As shown in
Fig. 3 B, rcFLIP /  T cells have undergone five rounds of
cell division by 72 h after TCR activation using CD3
Figure 3. Defective proliferation of rcFLIP /  T cells in response to 
TCR stimulation. (A) Defective proliferation of T cells lacking cFLIP in 
response to TCR stimulation. Purified T cells from spleens of rcFLIP /  
(gray bars) and rcFLIP /  (black bars) mice were stimulated with medium 
alone (untx), anti-CD28 alone, anti-CD3 (0.1 or 1  g/ml) without or with 
1  g/ml anti-CD28, or 0.7 ng/ml IL-2. T cell proliferation was assessed by 
[3H]thymidine incorporation, and results shown were the mean counts per 
minute (cpm)   SE from triplicate samples. (B) Abnormal cell division in 
CFSE-labeled rcFLIP /  T cells. Purified CD4  T cells from rcFLIP /  and 
rcFLIP /  mice were labeled with CFSE and cultured with or without 1  g/ml 
of plate-bound anti-CD3 antibody for 24, 48, or 72 h. Histograms show 
the CFSE fluorescence profile of viable, CFSE-labeled, CD4-positive T cells. 
The numbers above the peaks in each histogram denote the number of cell 
divisions the T cells have undergone; undivided T cells reside in the right-
most peak (denoted by 0). (C) Normal induction of early activation marker 
CD69. CD69 expression was measured by flow cytometry on rcFLIP /  and 
control cells ( / ) treated with medium alone (untx), 1  g/ml anti-CD3, 
or anti-CD3 plus 1  g/ml anti-CD28 for 12 h. The numbers within each 
histogram represent the percentages of gated cells. (D) Normal expression 
of T cell activation marker CD25. CD25 (IL-2R ) expression was measured 
by flow cytometry on rcFLIP /  and control cells ( / ) similarly treated 
as in C for 24 h (top). The number within each histogram represents the 
percentage of gated cells. CD25 expression was assessed of cells within 
the 7-AAD–negative gate (outlined area), which is indicative of viable cells 
(bottom). The number above each dot plot represents the percentage of 
gated 7-AAD–negative cells.JEM VOL. 202, August 1, 2005 409
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cross-linking. In contrast, rcFLIP /  T cells remained un-
divided, appearing in the rightmost region where resting
cells reside (Fig. 3 B). Similar results were observed with
anti-CD3 and anti-CD28 costimulation of rcFLIP /  T
cells (unpublished data). Interestingly, CD69 and CD25,
surface markers for T cell activation, were equally induced
in rcFLIP /  and the control T cells after CD3 alone and
CD3 plus CD28 cross-linking (Fig. 3, C and D), indicat-
ing that some pathways downstream of TCR stimulation
may operate normally in rcFLIP /  cells. It should be
noted that measurement of these T cell activation markers
was limited to live cell populations (Fig. 3 D).
Because cFLIP is a known antiapoptotic protein, we ex-
amined whether the deficiency of cFLIP affects the viability
of T cells. Purified rcFLIP /  and rcFLIP /  T cells were un-
treated or stimulated with anti-CD3 antibody for 24 or 48 h,
and cells were harvested and stained with Annexin V and
Figure 4. Survival defect of rcFLIP /  T cells. (A) Enhanced sponta-
neous and TCR-induced cell death in T cells lacking cFLIP. Purified T cells 
from rcFLIP /  and rcFLIP /  mice were stimulated with medium alone 
(untx) or 1  g/ml of insoluble anti-CD3 antibody for 48 h. Cells were then 
stained with anti-Thy1.2, Annexin V, and 7-AAD and examined by flow 
cytometry. Analysis was performed on Thy1.2-positive cells. The percentage 
of gated cells in each quadrant is shown. (B) Cell viability histogram of 
purified T cells from rcFLIP /  (gray bars) and rcFLIP /  (black bars) mice 
stimulated with medium alone (untx), 1  g/ml anti-CD3, or anti-CD3 plus 
5  g/ml anti-CD28 for 24 and 48 h. Cell viability was assessed by flow 
cytometric analysis of 7-AAD–negative cells, and the results shown were 
the average percentage of cell viability   SD for duplicate samples. (C) The 
role of the Fas signal on rcFLIP /  T cell proliferation. Purified T cells from 
rcFLIP /  and rcFLIP /  mice were treated with medium alone (untx), 1 
 g/ml of insoluble anti-CD3 antibody without or with 1  g/ml anti-CD28 
antibody in the absence or presence of 10  g/ml of neutralizing anti-FasL 
antibody for 24 h. T cell proliferation was assessed by [3H]thymidine incor-
poration, and results shown are cpm   SE from triplicate samples.
Figure 5. Impaired rcFLIP /  T lymphocyte proliferation in response 
to TCR activation. (A, top) Viable cell counts by trypan blue exclusion 
from duplicate wells made of rcFLIP /  and rcFLIP /  T cells after 48 h of 
culture without or with 1  g/ml anti-CD3 treatment. Approximately twice 
as many rcFLIP /  cells were seeded in each well as compared with rcFLIP /  
cells. (bottom) Defective thymidine incorporation of rcFLIP /  T cells in 
response to TCR stimulation. rcFLIP /  (white bars) and rcFLIP /  (black 
and gray bars) T cells were cultured without or with 1  g/ml anti-CD3 
treatment as described in A (top), and proliferation was measured by 
[3H]thymidine incorporation with results shown as mean cpm   SE. 
(B) Impairment of cell cycle entry in rcFLIP /  T cells. Purified T cells from 
rcFLIP /  and rcFLIP /  mice were either untreated (untx) or treated with 
1  g/ml of plate-bound anti-CD3 antibody with or without 1  g/ml anti-
CD28 antibody. Cells were fixed and stained with FITC-labeled anti-BrdU 
antibody and 7-AAD. Cells in the different phases of the cell cycle (G0/G1, 
S, and G2/M) are indicated. The percentage of cells in the S and G2/M 
phases of the cell cycle is shown.THE ROLE OF CFLIP IN T CELLS | Chau et al. 410
7-amino-actinomycin D (7-AAD), which detect early apop-
totic and dead cells, respectively. A decrease in the viability
of  rcFLIP /  Thy1.2  T cells, compared with rcFLIP / 
controls, was evident at both time points examined (Fig. 4, A
and B). In fact, there was a mild increase of spontaneous cell
death in unstimulated rcFLIP /  cells cultured over the pe-
riod of 48 h (Fig. 4 A). This reduction of T cell viability was
not caused by increased FasL/Fas apoptotic signals (25) be-
cause neutralizing FasL (using an antibody) failed to prevent
cell death in rcFLIP /  or rcFLIP /  T cells in the early
stages of culturing and TCR stimulation (unpublished data).
Consistently, the neutralizing antibody against FasL could
not rescue the proliferation defect observed in rcFLIP /  T
cells (Fig. 4 C). This neutralizing antibody was capable of in-
hibiting FasL/Fas-induced apoptosis in wild-type thymocytes
(unpublished data), validating its ability to neutralize FasL.
rcFLIP /  T cells are defective in cell cycling in response 
to TCR stimulation
Although the defects shown by thymidine incorporation and
CFSE labeling of TCR-stimulated rcFLIP /  cells may be
partially explained by impaired cell survival, at least two lines
of evidence suggest that rcFLIP /  T cells may have additional
defects in cell proliferation. First, when an excess number of
rcFLIP /  T cells were plated such that after 48 h of TCR
stimulation equal numbers of viable rcFLIP /  and rcFLIP / 
cells were present, the proliferation of rcFLIP /  T cells, as
measured by thymidine incorporation, was still lower com-
pared with rcFLIP /  T cells (Fig. 5 A). Second, when the cell
cycle profile of TCR-stimulated T cells was analyzed by
BrdU incorporation and 7-AAD staining, rcFLIP /  T cells
showed severe impairment of cell cycle entry, both in re-
sponse to anti-CD3 alone and to anti-CD3 plus anti-CD28
stimulation (Fig. 5 B). The BrdU/7-AAD experiment also
revealed a slight increase in G2/M phase cells in unstimu-
lated rcFLIP /  populations (3.94%) compared with resting
rcFLIP /  cells (0.67%; Fig. 5 B). Collectively, the defective
TCR response of rcFLIP /  cells is likely caused by a combi-
nation of proliferation defect and enhanced apoptosis.
Although FADD- and caspase-8–deficient T cells are
both defective in TCR-activated responses, there are re-
markable differences reported between these two knockout
cells. Specifically, FADD /  and caspase-8 /  T cells fail to
proliferate in response to TCR stimulation because of de-
fects in cell cycle regulation and survival, respectively (11,
26). Interestingly, the observed phenotypes of rcFLIP /  T
cells resemble caspase-8 /  T cells in their impaired survival,
whereas caspase-8 /  cells show the defect only after TCR
stimulation. The cell cycling defect of rcFLIP /  T cells is
reminiscent of FADD /  T cells.
Stimulation of TCR triggers various intracellular signal-
ing cascades, including activation of ERK, which contribute
to cellular proliferation (27). FADD and caspase-8, however,
do not appear to play a major role in promoting most known
TCR signaling pathways, based on previous studies (11, 16).
Consistently, activation of the ERK pathway in response to
CD3 plus CD28 cross-linking did not appear to require
cFLIP (Fig. 6). In fact, TCR-induced ERK phosphorylation
appeared to be slightly enhanced in rcFLIP /  T cells, similar
to what was observed in caspase-8–deficient T cells (11).
DISCUSSION
The involvement of FADD and caspase-8 in TCR-mediated
responses is intriguing, but the molecular mechanisms re-
main completely unknown. As cFLIP is capable of associat-
ing with FADD/caspase-8 in death receptor signaling (28)
and of modulating their activities, we investigated whether
cFLIP is also involved in TCR signals. We demonstrated
that cFLIP plays an important physiological role in T cell
regulation. Importantly, cFLIP is required for the proper ex-
pansion of T cells in response to TCR stimulation. The
presence of cFLIP not only ensures the survival of T cells
with or without TCR activation, but also promotes proper
cycling of T cells on stimulation. These findings support the
possibility that this DED-containing protein may coordinate
the death/survival decision, as well as the process of prolifer-
ation in the same cell (2).
We observed an impairment of thymocyte development
and a reduction of T lymphocyte numbers in peripheral lym-
phoid organs in rcFLIP /  mice, suggesting that ES cells lack-
ing cFLIP are less capable of reconstituting or maintaining a
T cell compartment. An alternative approach of studying the
effect of cFLIP deficiency on T cells would be to generate a
T cell-specific cFLIP knockout mouse (see Zhang and He on
p. 395 of this issue). The tissue-specific knockout offers a
robust and independent assessment of cFLIP functions in T
cell lineage, but the deletion of cFLIP is restricted to and after
a certain developmental stage; e.g., lck-Cre deletes the tar-
geted gene from the late double negative stage 2 of thy-
mocyte development onward (29). In this regard, the Rag / 
complementation approach provides a complementary system
in which deficiency of cFLIP is inherited from the beginning
of T cell development. It may be worth pointing out that
mice harboring FADD-deficient T cells, derived from Rag / 
complementation, also showed a similar reduction of thy-
mocyte cellularity and a deficiency of DP cells (10, 30).
Figure 6. Competent TCR-induced ERK activation in rcFLIP /  
T cells. Competent activation of Erk in rcFLIP /  T cells. Purified T cells 
from rcFLIP /  and rcFLIP /  mice were untreated (0 min) or activated 
with 10  g/ml each of soluble anti-CD3 and anti-CD28 antibodies for the 
indicated time points. PMA plus calcium ionophore (100 ng/ml each) stim-
ulation ( ) compared with no treatment ( ) of purified T cells from wild-
type (129J strain) mice was used as a positive control for Erk phosphoryla-
tion. Phosphorylated Erk was detected using phosphospecific antibodies 
by Western blotting. Actin was used as a loading control. Arrows indicate 
the bands corresponding to the proteins of interest.JEM VOL. 202, August 1, 2005 411
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Transgenic mice expressing a dominant negative form of
FADD also exhibited a T cell developmental defect (14, 17,
18). Recently, an induced deletion of caspase-8 using Mx-
Cre and the interferon system, although not T cell specific,
revealed a severe defect in thymocyte development (20).
Despite the defect in thymocyte development and cellu-
larity, the numbers of peripheral FADD /  T lymphocytes
are comparable to the control counterparts in the Rag / 
complementation study (10). Unlike FADD /  T cells,
rcFLIP /  T cells showed deficiencies in both thymocyte
and peripheral T cell numbers. Both mutants may go
through similar lymphopenic environments, at least at some
stages, but FADD /  peripheral T cells are perhaps capable
of homeostatic proliferation and lack survival defects. In-
triguingly, a fraction of the unstimulated FADD /  T cells
show characteristics of activated blasts, high levels of the T
cell activation marker CD69, and early entry into the S
phase. However, typical markers of homeostatic prolifera-
tion are not, or perhaps are no longer, present in FADD / 
cells (10). In contrast, we observed increased expression of
homeostatic proliferation marker CD122 on rcFLIP /  T
lymphocytes (unpublished data), suggesting that some degree
of homeostatic proliferation does occur in rcFLIP /  mice.
The fact that the homeostatic proliferation is unable to fill up
the T cell compartment in the periphery of rcFLIP /  mice
suggests an intrinsic defect in survival/proliferation in vivo.
The exact nature of the signals mediated by FADD,
caspase-8, or cFLIP downstream of TCR triggering remains
largely unknown. An involvement of death receptor (DR)
signals in TCR signals remains a possibility, and signals
through FasL/Fas, or TL1A/DR3 have been reported to be
costimulatory for TCR activation (31, 32). However, a re-
cent report suggested that the subcellular compartmentaliza-
tion of FADD and caspase-8 induced by TCR stimulation is
distinct from that triggered by DR ligation (33). In addition,
T cells lacking competent Fas and TNFR1 proliferate nor-
mally in response to TCR activation (34).
It is also possible that the three DED proteins play a role
downstream of IL-2 signaling, secondary to TCR activation,
although STAT5 phosphorylation appears normal in acti-
vated FADD-DN T cells (19). Many of the TCR signaling
pathways leading to IL-2 production are reported to be nor-
mal in caspase-8 / (11), FADD-DN (16), and cFLIP /  T
cells, except for a defect of calcium flux in FADD-DN cells
(35). Furthermore, supplementation of TCR stimulation
with IL-2 does not rescue proliferation in these mutant cells
(11, 14, 17, 19). Alternatively, some DED proteins may
somehow communicate with other TCR signaling com-
plexes. One potential link came from a recent study showing
that caspase-8 and FADD could interact with Bcl-10 and
Malt-1, at least in a human T cell line, and play a role in the
NF- B signaling pathway (36). Whether or not cFLIP is in-
volved in this association remains to be investigated.
It is possible that the DED proteins may collaborate
downstream of TCR triggering. However, an alternative
scenario of mutual regulation among these proteins, as in
DR apoptotic signals, remains possible so that too much or
too little of the signals mediated by these DED proteins
would be detrimental to T cell proliferation. Indeed, the
phenotypes of FADD / , caspase-8 / , and cFLIP /  T cells
each exhibit its unique features. Further studies on the
downstream impact of the DED protein signaling complex
are important to sort out this issue.
One intriguing hint on the mechanism of the DED pro-
tein signaling is that during T cell proliferation, FADD appears
to be regulated by phosphorylation at serine 191 (S191, mu-
rine FADD) (37). Consistently, an unknown kinase has been
reported to phosphorylate FADD during the G2/M phase of
cell cycling (37). T cells expressing FADD bearing constitu-
tively phosphorylated S191 (FADD S191D) reproduced the
cell cycle defect observed in FADD /  T cells but had normal
Fas-induced apoptosis (38). Studies of FADD phosphorylation
may reveal the key to uncoupling the regulation of apoptosis
and proliferation mediated by cFLIP, FADD, and caspase-8.
MATERIALS AND METHODS
Reagents. DNA restriction enzymes were obtained from Boehringer and
GIBCO BRL. The phosphoglycerate kinase promoter–driven neomycin
and hygromycin cassettes were cloned in pBluescript. Rag /  and 129J mice
were purchased from the Jackson Laboratory. All antibodies used for flow
cytometry and stimulation purposes were obtained from BD Biosciences or
eBioscience. Geneticin (G418) and Hygromycin B were obtained from
GIBCO BRL. ES cells were cultured in DMEM supplemented with 15%
FCS (Sigma-Aldrich), 2 mM L-glutamine (GIBCO BRL), 2 mM sodium
pyruvate (GIBCO BRL), 50  M  -mercaptoethanol (GIBCO BRL), and
leukemia inhibitory factor. Lymphocytes were cultured in RPMI 1640 with
10% FCS (GIBCO BRL), 2 mM L-glutamine, 2 mM sodium pyruvate, and
50  M  -mercaptoethanol. BM cells were harvested and kept in Iscove’s
media supplemented with 2 mM L-glutamine and 50  M  -mercaptoetha-
nol until further use.
Generation of cFLIP heterozygous mutant ES cells by gene target-
ing. The cFLIP targeting construct consists of a 1.1-kb short arm and a 5.5-
kb long arm, which are located at 5  and 3 , respectively, outside of exon 1 of
the targeted cflip locus and the neomycin resistance gene inserted in the re-
verse orientation. Homologous recombination will result in replacement of
endogenous cflip exon 1, which contains the ATG starting codon, with the
selection marker. 5   106 E14K ES cells (129J mouse background) were elec-
troporated (0.34 kV, 250  F) with 5 nM of the linearized construct. 24 h
later, cells were selected in 300  g/ml G418 (neomycin) in complete ES me-
dia. Homologous recombinants were identified by PCR and further analyzed
by genomic Southern blot hybridization with the short arm as a probe. Prim-
ers used for PCR screening bind to a portion of the neomycin marker gene
(primer sequence: 5 -CTT ATG CAT AAA GGG CTG GCA AGA TG-3 )
and to a portion of the endogenous 5  piece of the short arm (primer se-
quence: 5 -CAA ATT AAG GGC CAG CTC ATT CCT CC-3 ).
Establishing cFLIP-null ES cells and blastocyst injection. The gen-
eration of cFLIP-null ES cells was established using two different methods.
The first method subjected cFLIP /  ES cells to high concentrations of
G418 (3–12 mg/ml), forcing them to undergo mitotic recombination
whereby the wild-type allele is replaced after duplication of the disrupted
allele. Surviving clones were confirmed as homozygous mutants by ge-
nomic Southern blot analysis as described in the previous section. The sec-
ond method used another targeting construct containing a hygromycin re-
sistance cassette to disrupt the remaining wild-type allele in cFLIP /  ES
cells. After electroporation, colonies were selected in both G418 and hygro-
mycin. The surviving clones were screened by PCR using primers 5 -AAGTHE ROLE OF CFLIP IN T CELLS | Chau et al. 412
CGC ATG CTC CAG ACT GCC TTG GGA A-3  and 5 -CAA ATT
AAG GGC CAG CTC ATT CCT CC-3  and confirmed by genomic
Southern blot analysis as mentioned in the previous section. cFLIP /  and
cFLIP /  ES cell clones were injected into E3.5 Rag /  (B6 background)
blastocysts and reimplanted into psuedopregnant ICR foster mothers. The
resulting chimeric offspring were subjected to tail bleeding to examine for
the presence of lymphocytes. All mice were maintained under pathogen-
free conditions in accordance with the guidelines of the Canadian Council
for Animal Care, and all animal studies were approved by the University
Health Network Animal Care Committee (protocol 00–155).
Northern blot analysis. 20  g of total RNA from ES cell clones was
fractionated on a formaldehyde-denaturing agarose gel, and ethidium bro-
mide was used to stain for the presence of ribosomal RNA (18S and 28S) to
check for RNA integrity and equal loading. The RNA was then transferred
to nitrocellulose membrane and probed sequentially with 32P-radiolabeled
full-length cFLIP and GADPH cDNAs.
Flow cytometry analysis. Single cell suspensions from thymus, spleen,
LN, BM, and Peyer’s patches were stained with a variety of mAbs conju-
gated to fluorescent moieties (BD Biosciences) to analyze the expression of
cell surface markers. Antibodies conjugated with FITC, PE, biotinylated
strepatavidin-conjugated RED670, and allophycocyanin allowed the simul-
taneous assessment of multiple surface markers per cell sample using a flow
cytometer (FACSCalibur; Becton Dickinson). Data was analyzed using
CellQuest software (Becton Dickinson).
T cell purification. Single cell suspensions were obtained from spleen
and LN (cervical, axillary, inguinal, and brachial) by running the tissues
through a 70- m mesh. RBCs were removed from spleens by incubating
suspended cells in sterile hypertonic lysis buffer (0.155 mM ammonium
chloride, 0.1 mM disodium EDTA, 0.01 M potassium bicarbonate) for 5
min on ice. One method used to enrich for T cells was by negative selec-
tion using magnetic Dynabeads (DynaL), depleting cells expressing B220 (B
cells), Gr-1 (granulocytes), and Mac-1 (macrophages), according to the
manufacturer’s instructions. An alternative method used to purify T cells
used MACS magnetic beads conjugated to anti-CD4 and anti-CD8 anti-
bodies (for positive selection) or biotinylated non–anti-CD4 antibody cock-
tail (for negative selection) to purify CD4 -only T cells, according to the
manufacturer’s instructions (Miltenyi Biotec).
[3H]Thymidine proliferation assay. 105 cells/well were seeded in 96-
well round-bottom plates in a total volume of 200  l RPMI-supplemented
media. T cells were stimulated with anti-CD3 antibodies (clones 145-2C11
or 17A2; BD Biosciences) with or without costimulatory anti-CD28 anti-
body (clone 37.51; BD Biosciences). To mimic ligation or aggregation of
TCR/CD3 in vivo, insoluble anti-CD3 antibody stimulation was prepared
as follows: wells were precoated with 10  g/ml of the appropriate second-
ary IgG antibody (Jackson ImmunoResearch Laboratories) overnight at
4 C. The next day, wells were washed with PBS and incubated with anti-
CD3   anti-CD28 antibodies for at least 3 h at 37 C. Wells were then
washed with PBS before adding the cells. Cells were stimulated for 48 h and
pulsed for an additional 8 h with 1  Ci [3H]thymidine per well. The
amount of [3H]thymidine incorporated by the cells was measured with a di-
rect  -counter (Matrix 96; Canberra Packard).
Cell death assay. 105 T cells/well (unpurified or purified) were seeded in
a 96-well dish and left untreated or treated with anti-CD3   anti-CD28
antibodies for 24 or 48 h. Cells were then stained for Thy1.2 or CD3 (T
cell markers), Annexin V, and 7-AAD to evaluate the cell viability.
BrdU proliferation assay. The BrdU Flow Kit (BD Biosciences) was
used for cell cycle analysis on peripheral T lymphocytes. After 48 h of TCR
stimulation, cells were pulsed for 90 min with 10  M BrdU, harvested, and
stained with antibodies against TCR or CD3 to identify T cells. Cells were
fixed and permeabilized to allow staining with anti-BrdU antibody conju-
gated to FITC. Cells were further stained with 7-AAD to assess cell cycle
position (i.e., G0/G1, S, G2/M phase) by flow cytometry.
CFSE labeling of T cells. Purified CD4  T cells were labeled with CFSE
as previously described (24). In brief, cells were resuspended at a density of
20   106 cells/ml in PBS. An equal volume of 5  M CFSE (Molecular
Probes) in PBS was added, and the cells were incubated for 5–10 min at room
temperature with intermittent mixing. An equal volume of FBS was added,
and the labeled T cells were washed in PBS and resuspended in supplemented
RPMI media. CFSE-labeled rcFLIP /  and rcFLIP /  T cells, were plated at
4   105 and 12   105 cells/well, respectively, in 48-well microtiter plates.
CFSE-labeled T cells were harvested at 24, 48, and 72 h after no treatment or
treatment with anti-CD3   anti-CD28 antibodies (1  g/ml each). All sam-
ples were analyzed by flow cytometry using 7-AAD and CD4 antibody.
Phospho-ERK Western blotting. Western blotting for phospho-ERK
was performed as previously described (39). In brief, 3   106 purified T cells
were stimulated with soluble anti-CD3 plus anti-CD28 (10  g/ml each)
followed by cross-linking with 10  g/ml of the appropriate secondary IgG
antibody (Jackson ImmunoResearch Laboratories) or with 100 ng/ml each
of PMA (Sigma-Aldrich) plus calcium ionophore (A23187; Sigma-Aldrich).
After incubation at 37 C for 5, 15, and 60 min (10 min for PMA plus iono-
phore), the cells were washed in PBS containing 10 mM Na3VO4 and lysed
in ice-cold lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 1% Triton X-100,
20 mM EDTA, 1 mM Na3VO4, 1 mM NaF, and protease inhibitors), sub-
jected to 10% SDS-PAGE, and transferred to polyvinylidene difluoride
membranes. Filters were incubated with antibodies against phospho-
ERK1/2 (Cell Signaling) or actin (Sigma-Aldrich). The protein–antibody
complexes were detected using the ECL detection system (GE Healthcare).
Western blotting for DED protein expressions in T cells. 3    106
purified CD4  T cells from FADD-DN transgenic mice (a gift from A.
Strasser, University of Melbourne, Parkville, Australia) and wild-type litter-
mates were seeded on 48-well plates precoated with anti-CD3 (1  g/ml)
and anti-CD28 (5  g/ml) antibodies. T cells were incubated at 37 C for 3,
6, 12, 24, and 48 h, after which the cells were pelleted and lysed in radioim-
munoprecipitation assay buffer (10 mM Tris-HCl, pH 7.4, 1 mM EGTA,
0.1% NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM Na3VO4, 10 mM NaF,
1 mM PMSF). 10  g of the protein lysates were fractionated on 4–20%
Tris-glycine polyacrylamide gels and transferred to polyvinylidene difluo-
ride membranes. Membranes were sequentially probed with antibodies
against cFLIP (Apotech), FADD (a gift from D. Goeddel, Z. Cao, and G.
Chen, Tularik/Amgen, San Francisco, CA), caspase-8 (Qbiogene), c-Myc
(a gift from L. Penn, University Health Network, Toronto, Canada), and
actin (Sigma-Aldrich). Protein–antibody complexes were detected using the
ECL detection system (GE Healthcare).
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